NCT07225946
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07225946
Title A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer (KLK2-PASenger)
Acronym KLK2-PASenger
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Valkyrie Clinical Trials RECRUITING Los Angeles California 90067 United States Details
MidLantic Urology RECRUITING Bala-Cynwyd Pennsylvania 19004 United States Details
Houston Metro Urology RECRUITING Houston Texas 77027 United States Details
Linkou Chang Gung Memorial Hospital RECRUITING Taoyuan District 333 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field